Armephaco JSC

Armephaco JSC Cash Conversion Cycle

The Cash Conversion Cycle (CCC) of Armephaco JSC (AMP.VN) as of Oct 18, 2026 is 159.23. In the previous year, Cash Conversion Cycle (CCC) was 191.46 — a change of -16.83% (lower).

Cash Conversion Cycle

159.23

YoY

-16.83%

Last updated:

Cash Conversion Cycle (CCC) of Armephaco JSC is 2025 159.23 . Cash Conversion Cycle (CCC) of Armephaco JSC was 2024 191.46 . It decreases by -16.83% lower compared to the previous year.

The Armephaco JSC Cash Conversion Cycle history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion Cycle
Date
Cash Conversion Cycle
Jan 1, 2018
149.51 VND
Jan 1, 2019
128.63 VND
Jan 1, 2020
206.34 VND
Jan 1, 2021
130.12 VND
Jan 1, 2022
147.40 VND
Jan 1, 2023
169.93 VND
Jan 1, 2024
191.46 VND
Jan 1, 2025
159.23 VND
The Armephaco JSC Cash Conversion Cycle history
YEARCash Conversion CycleYoY
159.23-16.83%
191.46+12.67%
169.93+15.29%
147.40+13.28%
130.12-36.94%
206.34+60.41%
128.63-13.97%
149.51-1.94%
152.47+13.04%
134.89+16.61%
115.67—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Armephaco JSC Stock analysis

What does Armephaco JSC do? Armephaco JSC, listed on the Vietnamese stock market with ticker AMP.VN and ISIN VN000000AMP7, is headquartered in Hanoi, Vietnam. The company went public through an IPO on January 12, 2017. Armephaco engages in the manufacture and distribution of pharmaceutical products and medical equipment. Its product range includes glucose meters, sphygmomanometers, hospital beds, medical examination tables, and syringe destroyers. The company also produces and trades a variety of medicines, such as antibiotics, vitamins, pain relievers, antipyretics, gastrointestinal treatments, and anti-allergic medications. Armephaco operates within the pharmaceutical and medical equipment sector, though specific industry classifications are not detailed. The company's website is http://armephaco.com.vn/. As a publicly traded entity, Armephaco provides healthcare-related products and services to the Vietnamese market, focusing on both medical devices and pharmaceuticals. The company's operations are centered in Hanoi, where it manages its manufacturing and distribution activities. No additional details regarding founding year, key personnel, acquisitions, or financial figures are provided in the available information. Armephaco JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Armephaco JSC stock

Cash Conversion Cycle (CCC) of Armephaco JSC is 159.23 in 2025.

Cash Conversion Cycle (CCC) of Armephaco JSC changed from 191.46 to 159.23, representing a -16.83% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Cycle (CCC) Armephaco JSC since 2006 – with annual values, charts, and detailed analysis.

The Cash Conversion Cycle measures how long it takes to convert inventory investments into cash from sales. A shorter CCC indicates more efficient working capital management.

CCC = DSO + DIO - DPO

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Cycle (CCC)'s Armephaco JSC with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Cycle (CCC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Cycle (CCC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Armephaco JSC

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Armephaco JSC